Sabin CA. The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS 16: S61-S68, 2002.

Tamalet C et al.. Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes. AIDS 17: 2383-2388, 2003.

Dragsted UB et al. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. Journal of Infectious Diseases 188: 635-642, 2003.

Heath KV et al.. Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. Current Drug Targets 4: 13-22, 2003.

Matheny SC. Clinical dilemmas in palliative care for HIV infection. Journal of the Royal Society of Medicine 94: 449-451, 2001.

Yeguez JF, Martinez SA, Sands DR, Sands LR, Hellinger MD. Colorectal malignancies in HIV-positive patients. American Surgeon 69: 981-987, 2003.

Powles T, Nelson M, Bower M. HIV-related lung cancer- a growing concern? Internatinal Journal of STD and AIDS 14: 647-651, 2003.

Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17: 2479-2486, 2003.

Rabinstein AA. Stroke in HIV-infected patients: a clinical perspective. Cerbrovascular Diseases 15: 37-44, 2003.

WHO 2005a. WHO definition of palliative care. http://www.who.int/cancer/palliative/definition/en/ 2005.

WHO 2005b. Palliative Care. http://www.who.int/hiv/topics/palliative/care/en/ , 2005.

Harding R, Karus D, Easterbrook P, Raveis V, Higginson I.J  and Marconi K. Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence. Sexually Transmitted Infections 2004: in press.

Easterbrook P and Meadway J. The changing epidemiology of HIV infection: New challenges for HIV palliative care. Journal of the Royal Society of Medicine 94: 442-448, 2001.